0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-07-13 Sage Accounts Production Advanced 2023 - FRS102_2023 600 600 600 xbrli:pure xbrli:shares iso4217:GBP 15001650 2023-07-13 2024-07-31 15001650 2024-07-31 15001650 2023-07-12 15001650 bus:Director1 2023-07-13 2024-07-31 15001650 core:AfterOneYear 2024-07-31 15001650 core:ShareCapital 2024-07-31 15001650 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-07-31 15001650 core:CostValuation core:Non-currentFinancialInstruments 2024-07-31 15001650 core:Non-currentFinancialInstruments 2024-07-31 15001650 bus:SmallEntities 2023-07-13 2024-07-31 15001650 bus:AuditExempt-NoAccountantsReport 2023-07-13 2024-07-31 15001650 bus:SmallCompaniesRegimeForAccounts 2023-07-13 2024-07-31 15001650 bus:PrivateLimitedCompanyLtd 2023-07-13 2024-07-31 15001650 bus:FullAccounts 2023-07-13 2024-07-31 15001650 1 2023-07-13 2024-07-31
COMPANY REGISTRATION NUMBER: 15001650
RB Investco Limited
Filleted Unaudited Accounts
31 July 2024
RB Investco Limited
Statement of Financial Position
31 July 2024
31 Jul 24
Note
£m
Fixed assets
Investments
5
600
Current assets
Debtors
6
600
----
Net current assets
600
-------
Total assets less current liabilities
1,200
Creditors: amounts falling due after more than one year
7
600
-------
Net assets
600
-------
Capital and reserves
Called up share capital
600
----
Shareholders funds
600
----
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
The company did not trade during the period and has made neither profit nor loss. For the period ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Directors' responsibilities: - The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476 ; - The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts .
These accounts were approved by the board of directors and authorised for issue on 10 April 2025 , and are signed on behalf of the board by:
D Castelblanco
Director
Company registration number: 15001650
RB Investco Limited
Notes to the Accounts
Period from 13 July 2023 to 31 July 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, WA14 2DT, United Kingdom.
2. Statement of compliance
These accounts have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The accounts have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The accounts are prepared in sterling, which is the functional currency of the entity.
The company was incorporated in the period, and the accounts presented reflect the period from incorporation on 13 July 2023 to 31 July 2024.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship (see hedge accounting policy). Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Employee numbers
The company has no employees in the period.
5. Investments
Other loans
£m
Cost
At 13 July 2023
Additions
600
----
At 31 July 2024
600
----
Impairment
At 13 July 2023 and 31 July 2024
----
Carrying amount
At 31 July 2024
600
----
The investment held is in RB IM Media JV.
6. Debtors
31 Jul 24
£m
Other debtors
600
----
7. Creditors: amounts falling due after more than one year
31 Jul 24
£m
Other loans
600
----
8. Events after the end of the reporting period
On 10 September 2024: An amount of £100m of recoverable balances, presented above in other debtors, was received. On 26 September 2024: The company paid an interim dividend of £ 100 m.
9. Controlling party
The immediate parent entity is RB AIV GP LLC . The registered office of RB AIV GP LLC is 667 Madison Avenue, Suite 1600, New York, United States, NY 10065.